Chambal Fertilisers and Chemicals (CHAMBLFERT) Q4 24/25 earnings summary
Event summary combining transcript, slides, and related documents.
Q4 24/25 earnings summary
9 Jul, 2026Executive summary
Q4 standalone revenue was INR 2,449 crore with PAT of INR 100 crore, up 16% year-over-year.
FY2025 EBITDA reached INR 2,838 crore, PAT was INR 1,657 crore, both up 17% and 24% year-over-year, respectively.
Crop Protection Chemicals and Speciality Nutrients saw strong growth, with 41% y-o-y contribution growth and 146% revenue growth in new territories for FY25.
Urea production and sales volumes increased year-over-year, with a ~3% improvement in energy efficiency and a 125 MT/day rise in production at Gadepan Plant I & II.
Technical Ammonium Nitrate (TAN) project progressing on schedule, with INR 650 crore spent to date out of a total INR 1,645 crore project cost.
Financial highlights
Standalone revenue for FY25 was INR 16,646 crore, down 7% year-over-year, mainly due to lower Urea and P&K sales volumes.
Standalone EBITDA rose 17% y-o-y to INR 2,838 crore, PAT up 24% to INR 1,657 crore, and consolidated PAT increased 29% to INR 1,649 crore.
Urea production: 3.461 million MT (up from 3.383 million MT); urea sales: 3.471 million MT (up from 3.256 million MT).
Crop Protection Chemicals & Speciality Nutrients net revenue grew from INR 926 crore in FY24 to INR 1,400 crore in FY25.
Standalone EPS for FY25 was INR 41.35, up from INR 32.19; consolidated EPS was INR 41.17, up from INR 30.84.
Outlook and guidance
18 new products planned for launch in FY26, including biofungicide and bionematicide, with hybrid seeds to be introduced in Q1 FY26.
TAN project to commence commercial operations in January 2026, with ramp-up to 80-90% capacity expected in FY27.
CapEx for FY25-26 projected at INR 1,200 crore, funded through internal accruals.
Normal monsoon forecast expected to support Kharif season performance and robust growth in crop protection.
Latest events from Chambal Fertilisers and Chemicals
- Q1 FY27 delivered higher margins and profit despite lower revenue, with robust segment performance.CHAMBLFERT
Q1 26/2731 Jul 2026 - Q3 saw strong profit and revenue growth, new product launches, and major capacity expansions.CHAMBLFERT
Q3 24/258 Jul 2026 - FY26 saw 25% revenue growth, 18% profit rise, and major TAN plant commissioning.CHAMBLFERT
Q4 25/268 Jul 2026 - EBITDA and PAT rose sharply, with zero long-term debt and strong crop protection growth.CHAMBLFERT
Q1 24/258 Jul 2026 - EBITDA and PAT surged year-over-year, supported by urea and CPCSM growth, and interim dividend declared.CHAMBLFERT
Q2 24/258 Jul 2026 - Strong revenue and profit growth, new launches, and interim dividend highlight robust performance.CHAMBLFERT
Q2 25/261 Jul 2026 - Strong Q3/9M growth driven by complex fertilizers, specialty nutrients, and TAN project progress.CHAMBLFERT
Q3 25/2612 Apr 2026 - Diversified agri-input leader with strong financials, expanding into industrial chemicals and sustainability.CHAMBLFERT
Investor presentation20 Mar 2026 - Profits and revenue rose on CPC, SN, and biologicals growth; TAN project 80% complete.CHAMBLFERT
Q1 25/2614 Oct 2025